GLP-1 RECEPTOR AGONISTS IN NON-ALCOHOLIC FATTY LIVER DISEASE: CURRENT EVIDENCE AND FUTURE PERSPECTIVES

Descargar Publicación
Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand